03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
3TC Tablets 150mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Responsible Party | Glaxo Operations UK Ltd |
Origin | UK |
Manufacturer | Glaxo Operations Ltd |
Origin | UK |
ATC | J05AF05 |
3TC Tablets 150mg* :
3TC Tablets 150mg* :
3TC Tablets 150mg* :
3TC Tablets 150mg* :
3TC Tablets 150mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
ALT increased | Very Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Blood creatine phosphokinase increased | Common |
Hepatic steatosis | Not known |
Hepatitis | Not known |
Hepatomegaly | Not known |
Lactic acidosis | Not known |
Muscle disorder | Not known |
Muscle spasms | Not known |
Myalgia | Not known |
Neuropathy peripheral | Not known |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Not known |
Pruritus | Common |
Rhabdomyolysis | Not known |
Skin rash | Common |
Thrombocytopenia (Thrombopenia) | Not known |
3TC Tablets 150mg* :
3TC Tablets 150mg* :
NB : Products With Same Indication |
Different Units By MoH Code
3TC Tablets 150mg* MoH 641 :
Form | Tablet, Film-Coated |
Package Size | Box of 60 |
Strength | 150mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 208368/97 |
Submission date | 01/01/1997 |
Registration Year | 1997 |
Archived Date | 2018 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 60 | |
● Public Price: | 1117.5 AED | ( 26,999,917.50 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 18,625 AED | ( 434,898.00 LBP ) |
● Pharmacy Price: | 931.18 AED | ( 22498239.98 LBP ) |
● Pricing Date: | 16/11/2019 | |
● Type: | Medicine Withdrawn |
● Country: | Switzerland | |
● Package Size: | 60 | |
● Public Price: | 205.3 CHF | ( 21,232,126.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 3,4217 CHF | ( 310,260.00 LBP ) |
● Exfactory Price: | 164.55 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File